生物活性：FTISADTSK-13C6,15N2 TFA is 13C- and 15N-labeled FTISADTSK (HY-P3146). FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1][2].
体外研究(In Vitro)：氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。
瑞禧生物 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量：1091.01
Formula：C3813C6H69F3N815N2O18
非标记 CAS：1431957-73-1
性状：固体
颜色：White to off-white
运输条件：Room temperature in continental US; may vary elsewhere.
储存方式：Sealed storage, away from moisture
Powder：-80°C：2 years
-20°C：1 year
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)